TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback

Get the Brief in your inbox

A daily, SEC-grounded read on the market — movers, earnings, and our boldest calls. Free.

TTENK/calls

SEC-grounded equity research — opinionated calls reasoned over real filings.

Research

  • The Brief
  • Markets
  • All Stocks
  • Screener
  • Discover
  • Research
  • The Flip Side
  • Track record

Tools

  • Compare
  • Congress trades
  • Events
  • Filing search
  • Options calculator
  • Leaderboards
  • Insider trades
  • 13F funds
  • Groups
  • Trending
  • News

More

  • Pricing
  • Feedback
  • Newsletter
  • Developers / API
  • Account
DisclosuresTermsPrivacy

Research & education only — not financial advice.TENK is not a registered investment adviser; calls are impersonal, generated from SEC filings and a delayed/third-party price feed, and may be wrong or out of date. The operator and an affiliated trading operation may hold or trade the securities TENK rates — see Disclosures. Do your own research.

EDGAR® is a registered trademark of the U.S. Securities and Exchange Commission. TENK/calls is an independent service and is not affiliated with, endorsed by, or approved by the U.S. Securities and Exchange Commission.

TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback

Pulling SEC filings + quote and writing the call…

TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback
← New search
Home›Stocks›SGI
SGI logo

SGI

SOMNIGROUP INTERNATIONAL INC.

Next earnings Aug 5, 2026 (before open) · consensus $0.57 EPS, $1.90B rev

Last earnings -10.1% on 2026-05-07

Hold
$78.43
▲ +0.36%
$78.43▲ +17.13%
over 1Y
L $61.33H $97.54
Earnings Dividend Split Congress buy Congress sellGrouped by date · hover a pin to expand
Today+0.4%
1W-0.2%
1M+15.4%
3M+7.9%
YTD-11.2%
1Y+17.1%
OverviewFinancialsValuationQualityTimelineFilings
Rating
Hold
Quality
C+
Valuation
Fair value
Filings
Clean
Hold
Conviction
Horizon
Long (>12mo)
12-mo target
$•••
Street · 14 analysts
Buy

Somnigroup's Mattress Firm deal made it the world's biggest bedding company, but it also lifted debt to $4.61B and EPS still fell — and 40x earnings prices perfection.

Revenue $7.48B · FY2025

The read

Fundamentals and price both look middling — no strong edge either way.

Somnigroup (the renamed Tempur Sealy) closed its transformative Mattress Firm acquisition on February 5, 2025, vertically integrating the leading U.S. bedding manufacturer with the largest U.S. specialty mattress retailer. The deal dominates the financials: revenue surged 51.6% to $7.48B (after holding flat near $4.9B for four straight years), gross profit jumped 57.0% to $3.18B, and total assets nearly doubled (+94.0%) to $11.6B. The company now operates 2,852 owned stores across three segments and reaches consumers in over 100 countries with Tempur-Pedic, Sealy and Stearns & Foster — a genuinely stronger competitive position and an omni-channel moat in a fragmented industry.

But the bottom line has not followed the top line. Net income was essentially flat at $384M (-0.1%) and diluted EPS actually fell 14.8% to $1.84, as the equity issued and debt taken on to fund the deal, plus integration costs and a 44.2% jump in D&A to $291M, ate the added revenue. The balance sheet is now materially more levered: long-term debt rose 22.7% to $4.61B, liabilities/equity climbed to 2.73x, current liabilities ($1.57B) exceed current assets ($1.29B), and cash collapsed 92.1% to $135M. Operating cash flow of $800M (+20.0%) covers the dividend ($127M, +37.4%) and interest, but financial flexibility is much tighter than before.

Is SGI a buy? The one-page verdict, explained →

The options angle

model · matches our verdict
Covered call~90d expiry
  • Long 100 shares @ ~78.43
  • Short call 82 @ ~5.16 est
debit $7,327max +$873max −$7,326BE 73.27

HOLD means own it, don't chase it — harvesting premium against the position matches the verdict.

Open in the calculator →

Educational template, not a trade recommendation. Strikes and premiums are Black-Scholes model estimates from the last close and 30-day realized volatility — real chains, spreads and IV will differ. Options involve substantial risk.

Financials · annual, by fiscal year

Line itemFY21FY22FY23FY24FY25
Revenue$4.93B$4.92B$4.93B$4.93B$7.48B
Gross profit$2.16B$2.05B$1.99B$2.03B$3.18B
Operating income$912M$681M$607M$634M$755M
Net income$625M$456M$368M$384M$384M
Diluted EPS$3.06$2.53$2.08$2.16$1.84
Net margin12.7%9.3%7.5%7.8%5.1%

10-year statements — income, cash flow, balance sheet & CSV export →

Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.

Key statistics

Valuation

Enterprise value$21.0B
EV / EBITDA20.1
EV / Sales2.8
EV / FCF33.2
P / FCF26.1
PEG (trailing)—
Earnings yield2.3%
FCF yield3.8%

Quality & risk

ROIC (est.)7.7%
Free cash flow$633M
Total debt$4.64B
Net cash-$4.51B
Altman Z-Score2.46 grey
Piotroski F-Score5/9

Capital returns

Buyback yield—
Dividend yield (est.)0.8%
Shareholder yield0.8%
Shares Δ YoY+0.9%

Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.

Disclosure timeline

SEC · 8-Ks + reports
Routine disclosure cadence — no material red flags in recent filings.
  1. 8-K Reg FD disclosure2026-06-04
  2. 8-K Charter / bylaws change2026-05-15
  3. 10-Q Quarterly report2026-05-08
  4. 8-K Reg FD disclosure2026-05-07
  5. 8-K Earnings results2026-05-07
  6. 8-K Material agreement2026-04-13
  7. 8-K Reg FD disclosure2026-04-13
  8. DEF 14A Proxy statement2026-03-31
  9. 10-K Annual report2026-02-27

Recent filings

all on EDGAR ↗
S-4Filing2026-06-24open ↗425Filing2026-06-04open ↗8-KPeriod ending 2026-06-042026-06-04open ↗SDFiling2026-05-27open ↗4Period ending 2026-05-222026-05-26open ↗144Filing2026-05-22open ↗4Period ending 2026-05-132026-05-15open ↗4Period ending 2026-05-132026-05-15open ↗4Period ending 2026-05-132026-05-15open ↗4Period ending 2026-05-132026-05-15open ↗4Period ending 2026-05-132026-05-15open ↗4Period ending 2026-05-132026-05-15open ↗

Quality score

C+
ValueGrowthProfitHealthMom.
ValueC-
GrowthB-
ProfitabilityB-
Financial healthB-
MomentumC-
  • ✓Revenue growing year-over-year
  • ✓Profitable (positive net income)
  • ✗Net margin above 10%
  • ✗Return on equity above 15%
  • ✗Liabilities below 2× equity
  • ✗P/E below 25

Fair value est.

$68.72

Fairly valued -12% vs price

cheapfair valueexpensive

Modified Graham: EPS $1.84 × (8.5 + 1.5 × 22.0% growth) × 0.90 quality = 37.4× multiple. An estimate, not a price target.

61.3352-week97.54
Revenue
$7.48B
+51.6% YoY
Net margin
5.1%
ROE
12.4%
P/E
42.6

SEC fundamentals · FY 2025

'21'22'23'24'25

■ revenue · ■ net income, by fiscal year

Revenue$7.48B+51.6%
Net income$384M-0.1%
Gross profit$3.18B+57.0%
Operating income$755M+19.0%
Diluted EPS$1.84-14.8%
Cash & equivalents$135M-92.1%
Total assets$11.6B+94.0%
Total liabilities$8.48B+56.8%
Stockholders' equity$3.11B+456.0%
Gross: 42.6%Op.: 10.1%L/E: 2.73x

Frequently asked

Is SOMNIGROUP INTERNATIONAL INC. (SGI) a buy?
SGI currently carries a Hold rating with 3/5 conviction, derived from its latest SEC filings. Somnigroup's Mattress Firm deal made it the world's biggest bedding company, but it also lifted debt to $4.61B and EPS still fell — and 40x earnings prices perfection.
What is SGI's fair value?
A Modified-Graham model based on SGI's SEC fundamentals estimates a fair value of about $68.72. It is an estimate from reported earnings, not a price target.
Is SGI overvalued or undervalued?
Against a Modified-Graham fair-value estimate, SGI currently appears fairly valued relative to its SEC-grounded earnings power.
What is SOMNIGROUP INTERNATIONAL INC.'s quality score?
SGI scores 61.611753958825965/100 (grade C+) on a SEC-grounded quality model spanning value, growth, profitability, financial health and momentum.

Sources: SEC EDGAR (CIK 0001206264, latest 10-Q filed 2026-05-08) · EODHD · Proprietary analysis · as of 6/21/2026, 8:45:24 PM.

›About this recommendation — produced by TENK/calls (tenkcalls.com), Luxembourg · not investment advice

AI-generated analysis, produced by our proprietary engine from SEC filing data.

Investment recommendation produced by TENK/calls (tenkcalls.com), Luxembourg. Completed Jun 21, 2026, 4:45 PM ET. Ratings & methodology: definitions · All recommendations to date: track record · Conflicts: disclosures. Not investment advice.

Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.

Insider activity

Form 4 · SEC

Last 90 days: 0 open-market buys · 2 sales

2026-05-22
Rusing Steven H
President & CEO Mattress Firm
Exercise10.4K @ $15.61$163K
2026-05-22
Rusing Steven H
President & CEO Mattress Firm
Sell5.36K @ $66.79$358K
2026-05-22
Rusing Steven H
President & CEO Mattress Firm
Sell1.30K @ $67.49$87.7K
2026-05-14
Dyer Simon
Director
Exercise2.34K
2026-05-14
Dyer Simon
Director
Tax702.00 @ $64.49$45.3K
2026-05-13
NEU RICHARD W
Director
Award2.66K
2026-05-13
Madden Meredith Siegfried
Director
Award2.66K
2026-05-13
Gates Cathy R.
Director
Award2.66K
2026-05-13
Dilsaver Evelyn S
Director
Award2.66K
2026-05-13
Cook Christopher Thomas
Director
Award2.66K
2026-05-13
Sachse Peter R
Director
Award2.66K

Held by tracked funds

Form 13F · SEC · quarterly
Third PointDan Loeb2.27M sh$168M
Point72 Asset ManagementSteve Cohen2.22M sh$164M
Renaissance Technologies494K sh$36.5M
Soros Fund Management179K sh$13.2M

As of each fund’s latest quarterly 13F — a delayed snapshot, not a live position. All tracked funds →

Dividends

Quarterly
Yield (TTM)
0.8%
Annual / share
$0.64
Last ex-date
2026-05-21
Last amount
$0.17
ex 2026-05-21paid 2026-06-04$0.17
ex 2026-03-05paid 2026-03-19$0.17
ex 2025-11-20paid 2025-12-04$0.15
ex 2025-08-21paid 2025-09-05$0.15
ex 2025-05-22paid 2025-06-05$0.15
ex 2025-03-06paid 2025-03-20$0.15

Source: EODHD. Yield = trailing-12-month dividends ÷ price.

Earnings history

beat/miss · move
2026-05-07Beat +1.9% est▼ -8.95%8-K ↗
2026-02-17Miss -1.0% est▼ -1.35%8-K ↗
2025-11-06Beat +9.6% est▲ +15.01%8-K ↗
2025-08-07Beat +3.1% est▲ +2.18%8-K ↗
2025-05-08—▲ +3.60%8-K ↗
2025-02-20—▼ -7.51%8-K ↗

Dates from 8-K (Item 2.02); beat/miss = reported EPS vs consensus (Finnhub, recent quarters); move = prior close → close on/after.

Congressional trades

all activity →

4 buys · 3 sells · 1 member · last 180d

+$8.00K net boughtlast trade 96d ago
$32.0K bought$24.0K sold
2026-04-06April McClain DelaneyBuy$1.00K–$15.0KPTR ↗
2026-04-06April McClain DelaneyBuy$1.00K–$15.0KPTR ↗
2026-04-06April McClain DelaneyBuy$1.00K–$15.0KPTR ↗
2026-04-06April McClain DelaneyBuy$1.00K–$15.0KPTR ↗
2026-03-10April McClain DelaneySell$1.00K–$15.0KPTR ↗
2026-02-02April McClain DelaneySell$1.00K–$15.0KPTR ↗
2026-02-02April McClain DelaneySell$1.00K–$15.0KPTR ↗
2025-11-21Lisa McClainSell$1.00K–$15.0KPTR ↗
2025-11-21Lisa McClainBuy$1.00K–$15.0KPTR ↗
2025-11-21Lisa McClainSell$1.00K–$15.0KPTR ↗
2025-10-06April McClain DelaneySell$1.00K–$15.0KPTR ↗
2025-08-13Lisa McClainBuy$1.00K–$15.0KPTR ↗

Self-reported periodic transaction reports (STOCK Act). Amounts are disclosed ranges; a trade may be a spouse's. Disclosures lag the trade by up to ~45 days. Source: House Clerk + Senate eFD.

Vs tracked universe

compare →

1194 tracked peers · median

TENK Score62 vs 67
Revenue growth51.6% vs 7.5%
Net margin5.1% vs 10.0%
Return on equity12.4% vs 12.0%
P/E42.6 vs 26.2